Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/29/12
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 07/31/19
End: 05/31/23
Due: 05/31/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy | NCT01598831 | Asahi Kasei Pharma America Corporation | user2@example.com | None | 2012-10-29 | 2019-02-28 | 2020-02-28 | - | - | 2025-07-14 |
| The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy | NCT03517501 | Asahi Kasei Pharma America Corporation | user2@example.com | None | 2019-07-31 | 2023-05-31 | 2024-05-31 | - | - | 2025-07-14 |